US and Global Medical Affairs, Evidence Generation Strategy
The Chief Medical Officer for Pfizer’s Rare Disease Business Unit, Sonal Bhatia spearheaded the company’s leadership in the rare disease community.
Expertise
- At Pfizer, she previously served as Vice President of North America Medical Affairs Lead for Rare Disease, playing a key role in the successful launch of Tafamidis
- Rising Star Award by the Healthcare Businesswomen’s Association (HBA)
- Speaker at various panels and conferences internationally, driving the future of Medical Affairs
Experience
- Preparing the healthcare marketplace for innovative solutions for the delivery of medicines to patients
- Real-world evidence generation for physicians
- Working with nonprofits focused on reducing disparities for access to cardiovascular health and healthy living and serving as a catalyst for change for women’s health